LY3844583
/ Eli Lilly
- LARVOL DELTA
Home
Next
Prev
1 to 7
Of
7
Go to page
1
May 10, 2024
A Study of LY3844583 in Healthy Participants and Participants With Atopic Dermatitis
(clinicaltrials.gov)
- P1 | N=102 | Terminated | Sponsor: Eli Lilly and Company | Completed ➔ Terminated; Study terminated due to lack of efficacy signal in atopic dermatitis participants.
Trial termination • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
January 25, 2024
A Study of LY3844583 in Healthy Participants and Participants With Atopic Dermatitis
(clinicaltrials.gov)
- P1 | N=102 | Completed | Sponsor: Eli Lilly and Company | Recruiting ➔ Completed | Trial completion date: Jun 2024 ➔ Jan 2024 | Trial primary completion date: Jun 2024 ➔ Jan 2024
Trial completion • Trial completion date • Trial primary completion date • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
August 01, 2023
A Study of LY3844583 in Healthy Participants and Participants With Atopic Dermatitis
(clinicaltrials.gov)
- P1 | N=86 | Recruiting | Sponsor: Eli Lilly and Company | Trial completion date: Jan 2024 ➔ Jun 2024 | Trial primary completion date: Jan 2024 ➔ Jun 2024
Trial completion date • Trial primary completion date • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
May 11, 2023
A Study of LY3844583 in Healthy Participants and Participants With Atopic Dermatitis
(clinicaltrials.gov)
- P1 | N=86 | Recruiting | Sponsor: Eli Lilly and Company | Trial primary completion date: Jul 2023 ➔ Jan 2024
Trial primary completion date • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
April 13, 2023
A Study of LY3844583 in Healthy Participants and Participants With Atopic Dermatitis
(clinicaltrials.gov)
- P1 | N=86 | Recruiting | Sponsor: Eli Lilly and Company | Trial primary completion date: Jan 2024 ➔ Jul 2023
Trial primary completion date • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
August 18, 2022
A Study of LY3844583 in Healthy Participants and Participants With Atopic Dermatitis
(clinicaltrials.gov)
- P1 | N=86 | Recruiting | Sponsor: Eli Lilly and Company | Not yet recruiting ➔ Recruiting
Enrollment open • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
August 03, 2022
A Study of LY3844583 in Healthy Participants and Participants With Atopic Dermatitis
(clinicaltrials.gov)
- P1 | N=86 | Not yet recruiting | Sponsor: Eli Lilly and Company
New P1 trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
1 to 7
Of
7
Go to page
1